Review of candidate vaccines for the prevention of Lassa fever

Review of candidate vaccines for the prevention of Lassa fever

The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by this pathogen is mostly limited to the West African c...

Full description

Bibliographic Details
Main Authors: O. D. Popova, O. V. Zubkova, T. A. Ozharovskaia, D. I. Zrelkin, D. V. Voronina, I. V. Dolzhikova, D. V. Shcheblyakov, B. S. Naroditsky, D. Yu. Logunov, A. L. Gintsburg
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2021-05-01
Series:Вопросы вирусологии
Subjects:
lassa virus
candidate vaccines
recombinant vaccines
recombinant viral vectors
Online Access:https://virusjour.crie.ru/jour/article/viewFile/493/308

Internet

https://virusjour.crie.ru/jour/article/viewFile/493/308

Similar Items